The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004–2014)

BACKGROUND: Current prognostic markers cannot adequately predict the clinical outcome of breast cancer patients. Therefore, additional biomarkers need to be included in routine immune panels. FOXA1 was a significant predictor of favorable outcome in primary breast cancer, while Nestin expression is...

Descripción completa

Detalles Bibliográficos
Autores principales: De Lara, Shahin, Nyqvist, Jenny, Werner Rönnerman, Elisabeth, Helou, Khalil, Kenne Sarenmalm, Elisabeth, Einbeigi, Zakaria, Karlsson, Per, Parris, Toshima Z., Kovács, Anikó
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394077/
https://www.ncbi.nlm.nih.gov/pubmed/30819139
http://dx.doi.org/10.1186/s12885-019-5373-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394077/
https://www.ncbi.nlm.nih.gov/pubmed/30819139
http://dx.doi.org/10.1186/s12885-019-5373-2

Ejemplares similares